The incidence and management of tolerance in intrathecal baclofen therapy

Spinal Cord

Volumn 47, Issue 10, 2009, Pages 751-756

  Heetla, H W ^a   Staal, M J ^a   Kliphuis, C ^a   Van Laar, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Intrathecal baclofen; Spasticity; Tolerance

Indexed keywords

BACLOFEN; BENZODIAZEPINE; CLONAZEPAM; TIZANIDINE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; DECUBITUS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG IMPLANT; DRUG INFUSION; DRUG TOLERANCE; DYSPHAGIA; FEMALE; HUMAN; INFUSION PUMP; INFUSION SYSTEM; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPASTICITY; SPEECH DISORDER; URINE INCONTINENCE;

ADOLESCENT; ADULT; AGED; BACLOFEN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; NEURAL INHIBITION; RECEPTORS, GABA-B; RETROSPECTIVE STUDIES; SPINAL CORD; SPINAL CORD INJURIES; YOUNG ADULT;

EID: 70349739359     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.34     Document Type: Article

References (22)

1. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med 2000; 25: 117-157. (Pubitemid 30161444)
2. Deguchi Y, Inabe K, Tomiyasu K, Nozawa K, Yamada S, Kimura R. Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis. Pharm Res 1995; 12: 1838-1844. (Pubitemid 26031768)
3. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughlin JF. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003; 98: 291-295. (Pubitemid 36151022)
4. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 1992; 77: 236-240.
5. Koulousakis A, Kuchta J. Intrathecal antispastic drug application with implantable pumps: results of a 10 year follow-up study. Acta Neurochir Suppl 2007; 97: 181-184.
6. Akman MN, Loubser PG, Donovan WH, O'Neill ME, Rossi CD. Intrathecal baclofen: does tolerance occur? Paraplegia 1993; 31: 516-520.
7. Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987; 66: 181-185. (Pubitemid 17027874)
8. Stevens CW, Yaksh TL. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 1989; 250: 1-8.
9. Kroin JS, Bianchi GD, Penn RD. Intrathecal baclofen downregulates GABAB receptors in the rat substantia gelatinosa. J Neurosurg 1993; 79: 544-549. (Pubitemid 23289812)
10. Nielsen JF, Hansen HJ, Sunde N, Christensen JJ. Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen. Clin Neurol Neurosurg 2002; 104: 142-145. (Pubitemid 34262654)
11. Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226-232. (Pubitemid 23039122)
12. Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002; 83: 735-741. (Pubitemid 34721470)
13. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 1992; 71: 321-327. (Pubitemid 23016783)
14. Dario A, Scamoni C, Picano M, Casagrande F, Tomei G. Pharmacological complications of the chronic baclofen infusion in the severe spinal spasticity. Personal experience and review of the literature. J Neurosurg Sci 2004; 48: 177-181. (Pubitemid 40897331)
15. Taylor DA, Fleming WW. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 2001; 297: 11-18.
16. Ordia JI, Fischer E, Adamski E, Spatz EL. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996; 85: 452-457. (Pubitemid 26278028)
17. Vidal J, Gregori P, Guevara D, Portell E, Valles M. Efficacy of intrathecal morphine in the treatment of baclofen tolerance in a patient on intrathecal baclofen therapy (ITB). Spinal Cord 2004; 42: 50-51. (Pubitemid 38174981)
18. Zuckerbraun NS, Ferson SS, Albright AL, Vogeley E. Intrathecal baclofen withdrawal: emergent recognition and management. Pediatr Emerg Care 2004; 20: 759-764. (Pubitemid 39525247)
19. Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics 2005; 46: 503-507. (Pubitemid 41572170)
20. Sallerin-Caute B, Lazorthes Y, Monsarrat B, Cros J, Bastide R. CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol 1991; 40: 363-365.
21. Soni BM, Mani RM, Oo T, Vaidyanathan S. Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance - a case report and review of literature. Spinal Cord 2003; 41: 586-589. (Pubitemid 37260335)
22. Fluckiger B, Knecht H, Grossmann S, Felleiter P. Device-related complications of long-term intrathecal drug therapy via implanted pumps. Spinal Cord 2008; 46: 639-643.